|

Use of CGM in Kidney Transplant Recipients

RECRUITINGN/ASponsored by University of California, Davis
Actively Recruiting
PhaseN/A
SponsorUniversity of California, Davis
Started2021-06-29
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04783441

Summary

The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Age 18 or above
2. Received a kidney transplant within the past year with functioning kidney (eGFR \> 30 mL/min
3. Person with Type 2 Diabetes and on insulin
4. Access to home wi-fi connection

Exclusion Criteria:

1. Person with Type 1 Diabetes
2. Patients taking hydroxyurea
3. Patient unable to wear the Dexcom G6 device at all times for any reason
4. Must be able to test blood glucose with meter 4x a day when on blinded CGM.
5. Presence of clinically significant visual or cognitive impairment
6. Illiterate
7. Prisoners
8. Women who are pregnant, who plan to become pregnant during the course of the study, or who are breastfeeding
9. Presence of clinically unstable cardiovascular disease
10. Active malignancy treatment

Conditions4

DiabetesDiabetes Mellitus, Type 2Insulin Dependent DiabetesKidney Transplant; Complications

Locations1 site

UC Davis Health
Sacramento, California, 95817
Dahlia Zuidema, PharmD916-734-4009dmzuidema@ucdavis.edu

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.